In contrast, most research on NOS polymorphisms in COVID-19 has focused on the endothelial isoform (eNOS/NOS3), with some studies suggesting that variants in NOS3 may influence disease course in specific populations—particularly younger individuals without comorbidities—via effects on vascular and OS pathways. This evidence concerns the gene NOS3 and COVID-19.